Your browser doesn't support javascript.
loading
Discovery of a Potent and Selective CDKL5/GSK3 Chemical Probe That Is Neuroprotective.
Ong, Han Wee; Liang, Yi; Richardson, William; Lowry, Emily R; Wells, Carrow I; Chen, Xiangrong; Silvestre, Margaux; Dempster, Kelvin; Silvaroli, Josie A; Smith, Jeffery L; Wichterle, Hynek; Pabla, Navjot S; Ultanir, Sila K; Bullock, Alex N; Drewry, David H; Axtman, Alison D.
Afiliação
  • Ong HW; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Liang Y; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Richardson W; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K.
  • Lowry ER; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Wells CI; The Project ALS Therapeutics Core, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Chen X; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Silvestre M; Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, U.K.
  • Dempster K; Kinases and Brain Development Laboratory, The Francis Crick Institute, London NW1 1AT, U.K.
  • Silvaroli JA; Kinases and Brain Development Laboratory, The Francis Crick Institute, London NW1 1AT, U.K.
  • Smith JL; Division of Pharmaceutics and Pharmacology, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States.
  • Wichterle H; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
  • Pabla NS; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Ultanir SK; The Project ALS Therapeutics Core, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Bullock AN; Departments of Neurology, Neuroscience, Rehabilitation and Regenerative Medicine, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Drewry DH; Center for Motor Neuron Biology and Disease, Columbia University Irving Medical Center, New York, New York 10032, United States.
  • Axtman AD; Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, New York 10032, United States.
ACS Chem Neurosci ; 14(9): 1672-1685, 2023 05 03.
Article em En | MEDLINE | ID: mdl-37084253
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Quinase 3 da Glicogênio Sintase Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Quinase 3 da Glicogênio Sintase Limite: Humans Idioma: En Revista: ACS Chem Neurosci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos